-
TriAltus Bioscience Protein Purification Technology Supports Providence Cancer Institute COVID-19 Vaccine Development
Novel CL7/Im7 system enables rapid, high-purity, high-yield production of Coronavirus S-Spike proteins for research
BIRMINGHAM, Ala.–(BUSINESS WI...
-
TriAltus Bioscience to Present Abstract on Single-Step Cas9 Protein Purification with CL7/Im7 Affinity Tag System at PepTalk 2020
Breakthrough technique enables rapid, high-purity production of Cas9 proteins supporting accurate and efficient CRISPR genome editing
BIRMING...
-
TriAltus Bioscience Launches Im7 Affinity Chromatography Resin with Increased Binding Capacity
Modification doubles binding capacity for CL7/Im7 single-step protein purification system
BIRMINGHAM, Ala. – TriAltus Bioscience, LLC today annou...
-
Chinese Scientists Use TriAltus Bioscience’s CL-7 Purification System to Purify CRISPR-associated Proteins
BIRMINGHAM, Ala. (August 29, 2018)—TriAltus Bioscience, LLC today announced that scientists at Hubei University in China successfully co-expressed...
Use left/right arrows to navigate the slideshow or swipe left/right if using a mobile device